Carlisle Companies, Inc.
CSLNYSECIK 790051Basic Materials / Chemicalsfiscal year ends December70 quarters since 2009
Latest quarter Q3 FY2026, filed October 29, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of October 29, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 24, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 30, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,463 | 1,570 | 1,052 | 1,128 | 1,347 | 1,450 | 1,096 | 1,123 | +8.6% |
| Cost of revenue | 969 | 1,002 | 689 | 747 | 862 | 908 | 710 | 717 | +12.4% |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | 12 | 11 | 12 | 13 | 12 | 11 | 11 | 9 | −4.0% |
| Selling, general and administrative | 186 | 199 | 172 | 177 | 178 | 197 | 194 | 175 | +4.6% |
| Operating income | 293 | 353 | 180 | 190 | 294 | 335 | 184 | 224 | −0.2% |
| Other income (expense) | (2) | 2 | 2 | (1) | (2) | 2 | 0 | (21) | −6.3% |
| Pretax income | 270 | 334 | 163 | 172 | 278 | 324 | 175 | 202 | −2.8% |
| Income tax | 63 | 76 | 36 | 39 | 64 | 68 | 35 | 40 | −2.8% |
| Net income | 208 | 255 | 128 | 127 | 214 | 256 | 143 | 163 | −2.8% |
| Diluted EPS ($) | 5.24 | 6.30 | 3.10 | — | 4.98 | 5.88 | 3.20 | — | +5.2% |
| Diluted shares (millions) | 40 | 41 | 41 | — | 43 | 43 | 45 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 24, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 30, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 547 | 665 | 771 | 1,112 | 1,105 | 68 | 220 | 754 | −50.5% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 2,104 | 2,297 | 2,032 | 2,277 | 2,483 | 1,527 | 1,532 | 1,926 | −15.3% |
| Total assets | 6,030 | 6,235 | 5,990 | 6,263 | 6,457 | 5,519 | 5,451 | 5,817 | −6.6% |
| Total current liabilities | 875 | 883 | 601 | 736 | 765 | 697 | 593 | 666 | +14.4% |
| Long-term debt | 2,887 | 2,885 | 2,884 | 2,882 | 2,879 | 1,892 | 1,891 | 1,887 | +0.3% |
| Total liabilities | — | — | — | — | — | — | — | — | — |
| Stockholders’ equity | 1,438 | 1,617 | 1,653 | 1,795 | 1,992 | 2,121 | 2,167 | 2,463 | −27.8% |
| Shares outstanding (millions) | 39 | 40 | 40 | 41 | 42 | 43 | 43 | 45 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 30, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 24, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 13, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 30, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 24, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 314 | 242 | (45) | 386 | 427 | 287 | 2 | 371 | −26.4% |
| Capital expenditures | 37 | 42 | 28 | 40 | 34 | 29 | 29 | 37 | +9.9% |
| Free cash flow (CFO − capex) | 277 | 200 | (73) | 346 | 393 | 258 | (27) | 334 | −29.5% |
| Depreciation and amortization | 49 | 49 | 49 | 50 | 50 | 49 | 48 | 46 | −2.0% |
| Share repurchases | 350 | 250 | 250 | 300 | 300 | 300 | 400 | 420 | +16.7% |
| Dividends paid | 50 | 44 | 46 | 46 | 47 | 43 | 45 | 45 | +5.3% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 13, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 13, 2026 | FY2024ended Dec 31, 2024filed Feb 14, 2025 | FY2023ended Dec 31, 2023filed Feb 16, 2024 | FY2022ended Dec 31, 2022filed Feb 16, 2023 | FY2021ended Dec 31, 2021filed Feb 17, 2022 | FY2020ended Dec 31, 2020filed Feb 11, 2021 | FY2019ended Dec 31, 2019filed Feb 10, 2020 | FY2018ended Dec 31, 2018filed Feb 14, 2019 | FY2017ended Dec 31, 2017filed Feb 16, 2018 | FY2016ended Dec 31, 2016filed Feb 13, 2017 | FY2015ended Dec 31, 2015filed Feb 8, 2016 | FY2014ended Dec 31, 2014filed Feb 10, 2015 | FY2013ended Dec 31, 2013filed Feb 19, 2014 | FY2012ended Dec 31, 2012filed Feb 12, 2013 | FY2011ended Dec 31, 2011filed Feb 10, 2012 | FY2010ended Dec 31, 2010filed Feb 16, 2011 | FY2009ended Dec 31, 2009filed Jul 27, 2010 | FY2008ended Dec 31, 2008filed Feb 16, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,020 | 5,004 | 4,587 | 5,449 | 3,837 | 3,970 | 4,485 | 4,480 | 3,751 | 3,425 | 3,543 | 3,204 | 2,943 | 2,851 | 2,492 | 2,528 | 2,258 | 2,865 |
| Cost of revenue | 3,227 | 3,116 | 2,953 | 3,583 | 2,741 | 2,833 | 3,179 | 3,305 | 2,703 | 2,339 | 2,537 | 2,385 | 2,197 | 2,084 | 1,908 | 1,999 | 1,768 | 2,323 |
| Gross profit | — | — | 1,634 | 1,866 | — | — | 1,372 | 1,175 | 1,048 | 1,157 | 1,007 | 820 | 746 | 767 | 677 | 529 | — | — |
| Research and development | 47 | 35 | 29 | 19 | 16 | 45 | 52 | 55 | 51 | 45 | 43 | 34 | 29 | 26 | 22 | 23 | 16 | 16 |
| Selling, general and administrative | 745 | 723 | 625 | 624 | 508 | 603 | 630 | 625 | 533 | 495 | 462 | 379 | 354 | 357 | 299 | 311 | 274 | 298 |
| Operating income | 1,003 | 1,143 | 983 | 1,205 | 573 | 488 | 634 | 509 | 464 | 404 | 503 | 408 | 367 | 372 | 266 | 196 | 212 | 153 |
| Other income (expense) | (1) | (19) | 3 | (2) | (4) | (3) | (1) | (10) | (1) | 6 | (1) | — | — | — | — | — | — | — |
| Pretax income | 949 | 1,111 | 930 | 1,124 | 490 | 404 | 575 | 446 | 429 | 379 | 468 | 376 | 333 | 346 | 245 | 188 | 203 | 125 |
| Income tax | 206 | 246 | 212 | 266 | 104 | 79 | 117 | 87 | 88 | 148 | 148 | 124 | 98 | 118 | 73 | 57 | 48 | 34 |
| Net income | 741 | 1,312 | 767 | 924 | 422 | 320 | 473 | 611 | 366 | 250 | 320 | 251 | 210 | 270 | 180 | 146 | 145 | — |
| Diluted EPS ($) | 17.12 | 27.82 | 15.18 | 17.56 | 7.91 | 5.80 | 8.19 | 10.02 | 5.71 | 3.82 | 4.82 | 3.82 | 3.22 | 4.22 | 2.86 | 2.34 | 2.34 | 0.91 |
| Diluted shares (millions) | 43 | 47 | 50 | 53 | 53 | 55 | 58 | 61 | 64 | 65 | 66 | 65 | 65 | 64 | 62 | 62 | 61 | — |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 13, 2026 | FY2024ended Dec 31, 2024filed Feb 14, 2025 | FY2023ended Dec 31, 2023filed Feb 16, 2024 | FY2022ended Dec 31, 2022filed Feb 16, 2023 | FY2021ended Dec 31, 2021filed Feb 17, 2022 | FY2020ended Dec 31, 2020filed Feb 11, 2021 | FY2019ended Dec 31, 2019filed Feb 10, 2020 | FY2018ended Dec 31, 2018filed Feb 14, 2019 | FY2017ended Dec 31, 2017filed Feb 16, 2018 | FY2016ended Dec 31, 2016filed Feb 13, 2017 | FY2015ended Dec 31, 2015filed Feb 8, 2016 | FY2014ended Dec 31, 2014filed Feb 10, 2015 | FY2013ended Dec 31, 2013filed Feb 19, 2014 | FY2012ended Dec 31, 2012filed Feb 12, 2013 | FY2011ended Dec 31, 2011filed Feb 10, 2012 | FY2010ended Dec 31, 2010filed Feb 16, 2011 | FY2009ended Dec 31, 2009filed Jul 27, 2010 | FY2008ended Dec 31, 2008filed Feb 16, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1,112 | 754 | 577 | 365 | 324 | 897 | 351 | 804 | 378 | 385 | 411 | 731 | 755 | — | — | — | — | — |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | 2,277 | 1,926 | 3,408 | 2,245 | 2,151 | 2,209 | 1,752 | 2,057 | 1,645 | 1,355 | 1,320 | 1,612 | 1,535 | 1,205 | 1,214 | 1,017 | 800 | — |
| Total assets | 6,263 | 5,817 | 6,620 | 7,222 | 7,247 | 5,866 | 5,496 | 5,249 | 5,300 | 3,966 | 3,951 | 3,755 | 3,493 | 3,457 | 3,138 | 2,530 | 1,914 | — |
| Total current liabilities | 736 | 666 | 1,186 | 1,078 | 1,170 | 646 | 899 | 596 | 659 | 514 | 606 | 392 | 376 | 471 | 597 | 456 | 301 | — |
| Long-term debt | 2,882 | 1,887 | 1,887 | 2,281 | 2,575 | 2,080 | 1,341 | 1,588 | 1,586 | 596 | 596 | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stockholders’ equity | 1,795 | 2,463 | 2,829 | 3,024 | 2,630 | 2,538 | 2,643 | 2,597 | 2,528 | 2,467 | 2,347 | 2,205 | 1,986 | 1,788 | 1,500 | 1,341 | 1,219 | 1,094 |
| Shares outstanding (millions) | 41 | 45 | 48 | 51 | 52 | 53 | 56 | 57 | 62 | 65 | 64 | 65 | 64 | 63 | 62 | 61 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 13, 2026 | FY2024ended Dec 31, 2024filed Feb 14, 2025 | FY2023ended Dec 31, 2023filed Feb 16, 2024 | FY2022ended Dec 31, 2022filed Feb 16, 2023 | FY2021ended Dec 31, 2021filed Feb 17, 2022 | FY2020ended Dec 31, 2020filed Feb 11, 2021 | FY2019ended Dec 31, 2019filed Feb 10, 2020 | FY2018ended Dec 31, 2018filed Feb 14, 2019 | FY2017ended Dec 31, 2017filed Feb 16, 2018 | FY2016ended Dec 31, 2016filed Feb 13, 2017 | FY2015ended Dec 31, 2015filed Feb 8, 2016 | FY2014ended Dec 31, 2014filed Feb 10, 2015 | FY2013ended Dec 31, 2013filed Feb 19, 2014 | FY2012ended Dec 31, 2012filed Feb 12, 2013 | FY2011ended Dec 31, 2011filed Feb 10, 2012 | FY2010ended Dec 31, 2010filed Feb 16, 2011 | FY2009ended Dec 31, 2009filed Jul 27, 2010 | FY2008ended Dec 31, 2008filed Feb 16, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,102 | 1,030 | 1,201 | 1,001 | 422 | 697 | 703 | 339 | 459 | 531 | 529 | 296 | 415 | 486 | 191 | 107 | 417 | 274 |
| Capital expenditures | 131 | 113 | 142 | 184 | 135 | 96 | 89 | 121 | 160 | 109 | 72 | 119 | 111 | 140 | 80 | 65 | 48 | 68 |
| Free cash flow (CFO − capex) | 971 | 917 | 1,059 | 817 | 287 | 601 | 614 | 219 | 299 | 422 | 457 | 177 | 304 | 346 | 112 | 43 | 369 | 206 |
| Depreciation and amortization | 197 | 173 | 151 | 159 | 120 | 224 | 205 | 191 | 169 | 138 | 129 | 104 | 114 | 105 | 88 | 72 | 68 | — |
| Share repurchases | 1,300 | 1,586 | 900 | 400 | 316 | 382 | 382 | 460 | 268 | 75 | 137 | — | — | — | — | — | 1 | 5 |
| Dividends paid | 181 | 172 | 160 | 134 | 113 | 112 | 103 | 94 | 92 | 85 | 72 | 61 | 54 | 48 | 44 | 41 | 39 | 37 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Singh Jesse G | Director | option exercise | 4,070 | — | — | 8,752 | Sep 11, 2026 |
| Sep 10, 2026 | Singh Jesse G | Director | disposition to issuer | 505 | $0.00 | — | 8,247 | Sep 11, 2026 |
| Sep 10, 2026 | Frias James D | Director | other | 197 | $329.74 | $65K | 5,723 | Sep 10, 2026 |
| Sep 10, 2026 | Ricard Corrine D. | Director | other | 197 | $329.74 | $65K | 6,015 | Sep 10, 2026 |
| Apr 29, 2026 | Collins Jonathan R. | Director | option exercise | 5,902 | — | — | 9,029 | Apr 30, 2026 |
| Apr 28, 2026 | Palmer Sheryl | Director | award | 505 | $0.00 | — | 1,078 | Apr 28, 2026 |
| Apr 28, 2026 | Singh Jesse G | Director | award | 505 | $0.00 | — | 4,682 | Apr 28, 2026 |
| Apr 28, 2026 | Ricard Corrine D. | Director | award | 505 | $0.00 | — | 5,818 | Apr 28, 2026 |
| Apr 28, 2026 | Myers Charles David | Director | award | 505 | $0.00 | — | 2,173 | Apr 28, 2026 |
| Apr 28, 2026 | Hansen Maia | Director | award | 505 | $0.00 | — | 4,682 | Apr 28, 2026 |
| Apr 28, 2026 | Frias James D | Director | award | 505 | $0.00 | — | 5,526 | Apr 28, 2026 |
| Feb 19, 2026 | Easton Andrew C | VP & Chief Accounting Officer | open-market sale | 233 | $407.57 | $95K | 926 | Feb 19, 2026 |
| Feb 19, 2026 | Easton Andrew C | VP & Chief Accounting Officer | option exercise | 300 | $150.00 | $45K | 1,159 | Feb 19, 2026 |
| Feb 12, 2026 | Schwar Stephen | Vice Chair of CCM | option exercise | 1,500 | $108.72 | $163K | 14,589 | Feb 13, 2026 |
| Feb 12, 2026 | Schwar Stephen | Vice Chair of CCM | open-market sale | 1,500 | $417.16 | $626K | 13,089 | Feb 13, 2026 |
| Feb 12, 2026 | Schwar Stephen | Vice Chair of CCM | open-market sale | 4,549 | $417.42 | $2M | 8,540 | Feb 13, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 200 | $417.61 | $84K | 30,094 | Feb 11, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 2,533 | $416.69 | $1M | 30,294 | Feb 11, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 2,129 | $415.91 | $885K | 32,827 | Feb 11, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 128 | $408.06 | $52K | 34,956 | Feb 11, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 1,447 | $407.44 | $590K | 35,084 | Feb 11, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 4,199 | $406.26 | $2M | 36,531 | Feb 11, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 5,824 | $405.44 | $2M | 40,730 | Feb 11, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 5,414 | $406.08 | $2M | 46,554 | Feb 11, 2026 |
| Feb 10, 2026 | Zdimal Kevin P | VP & Chief Financial Officer | open-market sale | 2,306 | $405.19 | $934K | 51,968 | Feb 11, 2026 |
Full insider history for Carlisle Companies, Inc., or insider activity across all companies. A record of filings, not a recommendation.
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- CARLISLE COMPANIES INCORPORATED, CIK 790051 on EDGAR
- Extract generated
- November 4, 2026
- Withheld
- 8 line-years whose four quarters do not sum to the filed year: revenue FY2011, operating income FY2016, revenue FY2016, revenue FY2019, cost of revenue FY2020, revenue FY2020, cost of revenue FY2022, opex sga FY2022
- Repaired
- 1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2022
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNetCostOfGoodsAndServicesSoldGrossProfitResearchAndDevelopmentExpenseSellingGeneralAndAdministrativeExpenseOperatingIncomeLossOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsCurrentAssetsLiabilitiesCurrentLongTermDebtNoncurrentStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated November 4, 2026.
- JSON file
/data/financials/CSL.json